This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Covid-19 Diagnostics Market

Market Insights on Covid-19 Diagnostics covering sales outlook, demand forecast & up-to-date key trends

Covid-19 Diagnostics Market by Product Type (Instruments, Test Kits, Reagents and Consumables), Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine), Technology (PCR, ELISA, POC), End User & Region - Forecast to 2020 - 2030

Covid-19 Diagnostics Market Outlook and Findings

  • [280 Pages Report] The Covid-19 diagnostics market players look to develop highly sensitive and specific testing kits
  • RT-PCR remains the most widely used diagnostic test globally
  • Leading players boosting production by launching automated COVID-19 testing systems
  • Springing up of local players to combat Covid-19 providing a competitive edge to the market
Customize this Report

Let us know your requirement to get
100% FREE customization

Covid-19: A Snapshot

As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.

The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.

By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.

The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.

Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.

Key Market Trends

RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.

As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.

Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020-2030).

For instance –

  • In Jul 2020, Avacta announced beginning of clinical validation of high throughput Covid-19 laboratory test (Adeptrix Covid-19 diagnostic test) by collaborating with CONDOR program by the government of UK
  • In Jul 2020, BATM launched 3 novel diagnostic kits, namely – Covid-19 serologic test, Covid-19 antigen test, and new molecular diagnostics test for advancing Covid-19’s diagnosis
  • In July 2020, Mylab launched “Compact XL”, a machine for automating all the manual processes of molecular diagnostic tests, inclusive of Covid-19’s RT-PCR tests
  • In Jul 2020, The National Institute of Health selected the rapid Covid-19 test under the Rapid Acceleration of Diagnostics Tech (RADx Tech) program. Researchers at MIT, along with 3M have started with an accelerated research to check if a simple device could produce accurate results and its feasibility regarding mass production
  • In Jul 2020, Quest Diagnostics received authorization from the US FDA regarding laboratory technique to be employed in Covid-19 diagnostic testing
  • In June 2020, T2 Biosystems, Inc. announced that it had finished with validation of Covid-19 molecular diagnostic test – the “T2SARS-CoV-2 Panel” under license agreement with Hackensack Meridian Health’s Center of Discovery and Innovation. Distribution at the commercial level has been permitted after having met requirements for an EUA (Emergency Use Authorization) request to the US FDA
  • In Jun 2020, Mobidiag received CE-IVD markings relating to the two tests enabling reliable and rapid detection of Covid-19. They are – Amplidiag Covid-19 for catering to large laboratories for batch volume tests and Novodiag Covid-19 for on-demand, single tests
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Research and Offbeat Discoveries to Drive the Market

Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.

For instance –

  • In Jul 2020, AdvaMed announced creation of an exhaustive national Covid-19 diagnostic supply registry for lending a helping hand to federal and state pandemic responses.
  • In Jul 2020, The Journal of the American Osteopathic Association published a research paper that stated that obtaining eosinophil count also helps in detection of Covid-19. It also presented that out of Covid-19 patients, 60% did have zero eosinophils at presentation. The once not affected had not more than 16%.
  • India-based IIT Delhi, in Jul 2020, launched “Corosure”, the Covid-19 test kit at a base price of US $5 only.
  • In Jul 2020, SRL Diagnostics, in collaboration with Fortis Hospital, decided to launch antigen test facility to diagnose Covid-19 in Karnataka, India.

Players to fill the Void for asymptomatic Patients

Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.

To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.

On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.

Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.

Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Covid-19 Diagnostics Market: Regional Analysis

Covid-19 Diagnostics Market Download Report Brochure

The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.

Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.

Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market

Major Players in the Covid-19 Diagnostics Market

The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.

Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.

Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.

The other major players include:

  • Veredus Laboratories
  • Thermo Fisher Scientific, Inc.
  • Quidel Corporation
  • Perkin Elmer, Inc.
  • Neuberg Diagnostics
  • Mylab Discovery Solutions Pvt Ltd.
  • Luminex Corporation
  • Laboratory Corporation of America Holdings
  • Hologic Inc.
  • Danaher
  • Cepheid
  • bioMérieux SA
  • Altona Diagnostics GmbH
  • ALDATU BIOSCIENCES
  • ADT Biotech Sdn Bhd
  • Abbott
  • 1drop Inc.

Covid-19 Diagnostics market: The Way Forward

The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.

The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.

Key Segment

Product Type

  • Instruments
  • Test Kits
  • Reagents and Consumables

Sample Type

  • Oropharyngeal & Nasopharyngeal Swabs
  • Blood
  • Urine
  • Others

Technology

  • PCR
  • ELISA
  • POC

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.

The covid-19 diagnostics market size is estimated to cross US$ 204.51 Bn by 2032.

The covid-19 diagnostics market is likely to record a value of US$ 97.4 Bn in 2022.

Europe is likely to lead the covid-19 diagnostics market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Technology Adoption / Usage Analysis

    4.2. Key Product Features and their USPs

    4.3. Key Promotional Strategies, By Manufacturers

    4.4. Regulations, By Region

5. Global COVID-19 Diagnostics Market (Volume in Units) Analysis 2015-2019  and Forecast, 2020-2030

    5.1. Historical Market Volume (in Units) Analysis, 2015-2019

    5.2. Current and Future Market Volume (in Units) Projections, 2020-2030

6. Global COVID-19 Diagnostics Market - Pricing Analysis

    6.1. Average Pricing Analysis By Region

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global COVID-19 Diagnostics Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Global GDP Growth Outlook

        8.1.2. Per Capita Healthcare Expenditure Outlook

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Increase in R&D Funding and Grants

        8.2.2. Increase in Number of Corona Virus Disease Cases

        8.2.3. Diagnosis Seeking Rate

        8.2.4. COVID-19 Disease Mortality Rate

        8.2.5. Industry Consolidation to Increase Capacity

        8.2.6. Increase in Manufacturing Activity

    8.3. Market Dynamics

        8.3.1. Drivers

        8.3.2. Restraints

        8.3.3. Opportunity Analysis

    8.4. COVID19 Crisis Analysis

        8.4.1. Current COVID19 Statistics and Probable Future Impact

        8.4.2. Current GDP Projection and Probable Impact

        8.4.3. Current Economic Projection as compared to 2008 Economic analysis

        8.4.4. COVID19 and Impact Analysis

            8.4.4.1. Revenue By Product Type

            8.4.4.2. Revenue By Sample Type

            8.4.4.3. Revenue By Technology

            8.4.4.4. Revenue By End User

            8.4.4.5. Revenue By Country

        8.4.5. 2020 Market Scenario

        8.4.6. Quarter by Quarter Forecast

        8.4.7. Projected recovery Quarter

        8.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact

9. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019

    9.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2020-2030

        9.3.1. Instruments

        9.3.2. Test Kits

            9.3.2.1. Rapid Test Kits

            9.3.2.2. Assay Based Test Kits

        9.3.3. Reagents and Consumables

    9.4. Market Attractiveness Analysis By Product Type

10. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Sample Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Sample Type, 2015-2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2020-2030

        10.3.1. Oropharyngeal & Nasopharyngeal Swabs

        10.3.2. Blood

        10.3.3. Urine

        10.3.4. Others

    10.4. Market Attractiveness Analysis By Sample Type

11. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Technology

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030

        11.3.1. PCR

        11.3.2. ELISA

        11.3.3. POC

    11.4. Market Attractiveness Analysis By Technology

12. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

        12.3.1. Hospitals

        12.3.2. Speciality Clinics

        12.3.3. Diagnostic Centers

        12.3.4. Pathology Laboratories

        12.3.5. Research Institutes

    12.4. Market Attractiveness Analysis By End User

13. Global COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) & Volume Analysis By Region, 2015 - 2019

    13.3. Current Market Size (US$ Mn) & Volume Analysis and Forecast By Region, 2020 - 2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    14.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product Type

        14.3.3. By Sample Type

        14.3.4. By Technology

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    15.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product Type

        15.3.3. By Sample Type

        15.3.4. By Technology

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    16.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Product Type

        16.3.3. By Sample Type

        16.3.4. By Technology

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    17.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Sample Type

        17.3.4. By Technology

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    18.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product Type

        18.3.3. By Sample Type

        18.3.4. By Technology

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    19.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product Type

        19.3.3. By Sample Type

        19.3.4. By Technology

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

    20.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Product Type

        20.3.3. By Sample Type

        20.3.4. By Technology

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries COVID-19 Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. COVID-19 Diagnostics Market Analysis

        21.2.1. By Product Type

        21.2.2. By Sample Type

        21.2.3. By Technology

        21.2.4. By End User

    21.3. Canada COVID-19 Diagnostics Market Analysis

        21.3.1. By Product Type

        21.3.2. By Sample Type

        21.3.3. By Technology

        21.3.4. By End User

    21.4. Mexico COVID-19 Diagnostics Market Analysis

        21.4.1. By Product Type

        21.4.2. By Sample Type

        21.4.3. By Technology

        21.4.4. By End User

    21.5. Brazil COVID-19 Diagnostics Market Analysis

        21.5.1. By Product Type

        21.5.2. By Sample Type

        21.5.3. By Technology

        21.5.4. By End User

    21.6. U.K. COVID-19 Diagnostics Market Analysis

        21.6.1. By Product Type

        21.6.2. By Sample Type

        21.6.3. By Technology

        21.6.4. By End User

    21.7. Germany COVID-19 Diagnostics Market Analysis

        21.7.1. By Product Type

        21.7.2. By Sample Type

        21.7.3. By Technology

        21.7.4. By End User

    21.8. France COVID-19 Diagnostics Market Analysis

        21.8.1. By Product Type

        21.8.2. By Sample Type

        21.8.3. By Technology

        21.8.4. By End User

    21.9. Italy COVID-19 Diagnostics Market Analysis

        21.9.1. By Product Type

        21.9.2. By Sample Type

        21.9.3. By Technology

        21.9.4. By End User

    21.10. Spain COVID-19 Diagnostics Market Analysis

        21.10.1. By Product Type

        21.10.2. By Sample Type

        21.10.3. By Technology

        21.10.4. By End User

    21.11. BENELUX COVID-19 Diagnostics Market Analysis

        21.11.1. By Product Type

        21.11.2. By Sample Type

        21.11.3. By Technology

        21.11.4. By End User

    21.12. Russia COVID-19 Diagnostics Market Analysis

        21.12.1. By Product Type

        21.12.2. By Sample Type

        21.12.3. By Technology

        21.12.4. By End User

    21.13. China COVID-19 Diagnostics Market Analysis

        21.13.1. By Product Type

        21.13.2. By Sample Type

        21.13.3. By Technology

        21.13.4. By End User

    21.14. Japan COVID-19 Diagnostics Market Analysis

        21.14.1. By Product Type

        21.14.2. By Sample Type

        21.14.3. By Technology

        21.14.4. By End User

    21.15. South Korea COVID-19 Diagnostics Market Analysis

        21.15.1. By Product Type

        21.15.2. By Sample Type

        21.15.3. By Technology

        21.15.4. By End User

    21.16. India COVID-19 Diagnostics Market Analysis

        21.16.1. By Product Type

        21.16.2. By Sample Type

        21.16.3. By Technology

        21.16.4. By End User

    21.17. ASEAN COVID-19 Diagnostics Market Analysis

        21.17.1. By Product Type

        21.17.2. By Sample Type

        21.17.3. By Technology

        21.17.4. By End User

    21.18. Australia COVID-19 Diagnostics Market Analysis

        21.18.1. By Product Type

        21.18.2. By Sample Type

        21.18.3. By Technology

        21.18.4. By End User

    21.19. New Zealand COVID-19 Diagnostics Market Analysis

        21.19.1. By Product Type

        21.19.2. By Sample Type

        21.19.3. By Technology

        21.19.4. By End User

    21.20. GCC Countries COVID-19 Diagnostics Market Analysis

        21.20.1. By Product Type

        21.20.2. By Sample Type

        21.20.3. By Technology

        21.20.4. By End User

    21.21. Turkey COVID-19 Diagnostics Market Analysis

        21.21.1. By Product Type

        21.21.2. By Sample Type

        21.21.3. By Technology

        21.21.4. By End User

    21.22. South Africa COVID-19 Diagnostics Market Analysis

        21.22.1. By Product Type

        21.22.2. By Sample Type

        21.22.3. By Technology

        21.22.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Regional footprint of Players

        22.4.2. Product foot print by Players

        22.4.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Thermo Fisher Scientific, Inc.

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

                23.3.1.5.1. Marketing Strategy

                23.3.1.5.2. Product Strategy

                23.3.1.5.3. Channel Strategy

        23.3.2. Danaher

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

                23.3.2.5.1. Marketing Strategy

                23.3.2.5.2. Product Strategy

                23.3.2.5.3. Channel Strategy

        23.3.3. F. Hoffman-La Roche Ltd.

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy

        23.3.4. Hologic Inc.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. Laboratory Corporation of America Holdings

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Luminex Corporation

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. Mylab Discovery Solutions Pvt Ltd.

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Neuberg Diagnostics

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. Perkin Elmer, Inc.

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. Quest Diagnostics

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Quidel Corporation

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. Merck KGaA

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy

        23.3.13. Veredus Laboratories

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. Abbott Laboratories

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 02: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Product Type

Table 03: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 04: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Sample Type

Table 05: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Technology

Table 06: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By End User

Table 07: Global COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 08: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 09: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 10: North America COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 11: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 12: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 13: North America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 14: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 15: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 16: Latin America COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 17: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 18: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 19: Latin America COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 20: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 21: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 22: Europe COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 23: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 24: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 25: Europe COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 26: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 28: South Asia COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 29: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 30: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 31: South Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 32: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 33: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 34: East Asia COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 35: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 36: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 37: East Asia COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 38: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 39: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 40: Oceania COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 41: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 42: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 43: Oceania COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Table 44: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 45: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Product Type

Table 46: MEA COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 47: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Sample Type

Table 48: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Technology

Table 49: MEA COVID-19 Diagnostics Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global COVID-19 Diagnostics Market Volume (in '000 Unit) Analysis, 2015–2019

Figure 02: Global COVID-19 Diagnostics Market Volume (in '000 Unit) & Y-o-Y Growth (%) Analysis, 2020–2030

Figure 03: Global COVID-19 Diagnostics Market Value Share, By Product Type, 2019 (A)

Figure 04: Global COVID-19 Diagnostics Market Value Share, By Sample Type, 2019 (A)

Figure 05: Global COVID-19 Diagnostics Market Value Share, By Technology, 2019 (A)

Figure 06: Global COVID-19 Diagnostics Market Value Share, By End User, 2019 (A)

Figure 07: Global COVID-19 Diagnostics drugs Market Value Analysis 2015-2019 & 2020-2030

Figure 08: Global COVID-19 Diagnostics drugs Market Y-O-Y Growth Analysis By Region

Figure 09: Global COVID-19 Diagnostics Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 10: Global COVID-19 Diagnostics Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 11: Global COVID-19 Diagnostics Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 12: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Product Type, 2020 & 2030

Figure 13: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Product Type, 2020–2030

Figure 14: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020–2030

Figure 15: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Sample Type, 2020 & 2030

Figure 16: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Sample Type, 2020–2030

Figure 17: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020–2030

Figure 18: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Technology, 2020 & 2030

Figure 19: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Technology, 2020–2030

Figure 20: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020–2030

Figure 21: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By End User, 2020 & 2030

Figure 22: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By End User, 2020–2030

Figure 23: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020–2030

Figure 24: Global COVID-19 Diagnostics Drugs Market Share Analysis (%) By Region, 2020 & 2030

Figure 25: Global COVID-19 Diagnostics Drugs Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 26: Global COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Region, 2020–2030

Figure 27: North America COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 28: North America COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 29: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 30: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 31: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 32: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 33: North America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 34: Latin America COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 35: Latin America COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 36: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 37: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 38: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 39: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 40: Latin America COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 41: Europe COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 42: Europe COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 43: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 44: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 45: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 46: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 47: Europe COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 48: South Asia COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 49: South Asia COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 50: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 51: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 52: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 53: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 54: South Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 55: East Asia COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 56: East Asia COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 57: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 58: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 59: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 60: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 61: East Asia COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 62: Oceania COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 63: Oceania COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 64: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 65: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 66: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 67: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 68: Oceania COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 69: MEA COVID-19 Diagnostics Drugs Market Value Analysis, 2015–2019

Figure 70: MEA COVID-19 Diagnostics Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 71: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 72: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Product Type, 2020-2030

Figure 73: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Sample Type, 2020-2030

Figure 74: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By Technology, 2020-2030

Figure 75: MEA COVID-19 Diagnostics Drugs Market Attractiveness Analysis By End User, 2020-2030

Figure 76: US COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 77: US COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 78: US COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 79: US COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 80: Canada COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 81: Canada COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 82: Canada COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 83: Canada COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 84: Brazil COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 85: Brazil COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 86: Brazil COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 87: Brazil COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 88: Mexico COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 89: Mexico COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 90: Mexico COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 91: Mexico COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 92: Germany COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 93: Germany COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 94: Germany COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 95: Germany COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 96: Italy COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 97: Italy COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 98: Italy COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 99: Italy COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 100: France COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 101: France COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 102: France COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 103: France COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 104: U.K. COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 105: U.K. COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 106: U.K. COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 107: U.K. COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 108: Spain COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 109: Spain COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 110: Spain COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 111: Spain COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 112: BENELUX COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 113: BENELUX COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 114: BENELUX COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 115: BENELUX COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 116: Russia COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 117: Russia COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 118: Russia COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 119: Russia COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 120: China COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 121: China COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 122: China COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 123: China COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 124: Japan COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 125: Japan COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 126: Japan COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 127: Japan COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 128: South Korea COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 129: South Korea COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 130: South Korea COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 131: South Korea COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 132: India COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 133: India COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 134: India COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 135: India COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 136: Australia COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 137: Australia COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 138: Australia COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 139: Australia COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 140: New Zealand COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 141: New Zealand COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 142: New Zealand COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 143: New Zealand COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 144: GCC Countries COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 145: GCC Countries COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 146: GCC Countries COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 147: GCC Countries COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 148: South Africa COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 149: South Africa COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 150: South Africa COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 151: South Africa COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Figure 152: Turkey COVID-19 Diagnostics Market Value Share, By Product Type, 2020 (E)

Figure 153: Turkey COVID-19 Diagnostics Market Value Share, By Sample Type, 2020 (E)

Figure 154: Turkey COVID-19 Diagnostics Market Value Share, By Technology, 2020 (E)

Figure 155: Turkey COVID-19 Diagnostics Market Value Share, By End User, 2020 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Coronavirus Immunoassay Market

Published : June 2022

Healthcare

COVID-19 Saliva Sampling Test Potential Market

Published : June 2022

Healthcare

Covid-19 Vaccine Development Tools Market

Published : May 2022

Healthcare

Americas COVID-19 Testing Market

Published : July 2021

Google translate

Covid-19 Diagnostics Market